Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.23 | 9e-12 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.35 | 1e-11 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.21 | 1e-11 |
mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.23 | 1e-11 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.22 | 3e-11 |
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.35 | 5e-11 |
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.21 | 6e-11 |
mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.25 | 8e-11 |
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.21 | 1e-10 |
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.22 | 2e-10 |